December 17th 2018
Imugene's promising trial results: five patients with >30% decrease in tumour size
December 7th 2018
RotoGro buzzes on new strategic Affinity
November 26th 2018
BPH completes successful anaesthesia monitor trials
November 22nd 2018
ANP: Why partnering with big biotech has its benefits
November 19th 2018
Immuron appoints a new CEO to lead it into the future
November 13th 2018
Imugene's gastric cancer immuno-oncology trial advances to Phase 2
November 9th 2018
Good run continues for Imugene with $1.85M R&D tax incentive
November 1st 2018
Race Oncology pens key deal to seek chemo drug Bisantrene licensing
October 29th 2018
Prescient onboards former Array Biopharma executive
Strategic acquisition positions RotoGro in Canada's recreational cannabis market
October 25th 2018
BPH confirms intention to enter medical cannabis sector
October 24th 2018
Breakthrough Prize given to Antisense pioneer
Connect with us
